Your browser doesn't support javascript.
loading
A New Strategy for Trichomonas Testing Female Adolescents in the Emergency Department.
Territo, Heather M; Wrotniak, Brian H; Bouton, Scott; Burstein, Gale R.
Afiliação
  • Territo HM; Women and Children's Hospital of Buffalo, Buffalo, New York; Erie County Department of Health, Buffalo, New York. Electronic address: hterrito@buffalo.edu.
  • Wrotniak BH; Women and Children's Hospital of Buffalo, Buffalo, New York; D'Youville College, Buffalo, New York.
  • Bouton S; Women and Children's Hospital of Buffalo, Buffalo, New York.
  • Burstein GR; Women and Children's Hospital of Buffalo, Buffalo, New York; Erie County Department of Health, Buffalo, New York.
J Pediatr Adolesc Gynecol ; 29(4): 378-81, 2016 Aug.
Article em En | MEDLINE | ID: mdl-26820440
ABSTRACT
STUDY

OBJECTIVE:

Sensitive trichomonas diagnostic testing has become available, including nucleic acid amplification tests (NAATs) and a rapid antigen test. The study purpose was to determine if adding sensitive trichomonas testing to routine female sexually transmitted infection (STI) evaluations would increase trichomonas identification and treatment.

DESIGN:

Two study time periods. Study time 1 (T1) was used for a retrospective review. Study time 2 (T2) was used for a prospective study.

SETTING:

Emergency Department.

PARTICIPANTS:

Symptomatic female patients aged 13-20 years (N = 447).

INTERVENTIONS:

Implementation of routing trichomonas testing in the Emergency Department during T2. MAIN OUTCOME

MEASURES:

Trichomonas diagnosis and treatment rates were compared during T1 and T2.

RESULTS:

During T1 31 of 234 of eligible patients (13%) were trichomonas-tested. Laboratory-confirmed trichomonas was identified in 3 of 234 (1.3%). During T2, 212 of 213 of eligible patients (99.5%) were trichomonas-tested; 39 of 212 tested trichomonas-positive (18.4%); 29 of 212 tested rapid trichomonas antigen test-positive (13.6%; P < .001), and 33 of 188 tested trichomonas NAAT-positive (15.5%; P < .001). Trichomonas treatment was given to 3 of 3 laboratory-confirmed trichomonas cases during T1 (100%) compared with 37 of 39 during T2 (95%; P = .688). During T1, 14 of 17 women who received trichomonas treatment (82.4%) did not have a laboratory-confirmed trichomonas diagnosis and during T2 13 of 52 women without a laboratory-confirmed trichomonas diagnosis (25%) were treated for trichomonas (P < .001). Rapid trichomonas antigen tests and trichomonas NAATs were concordant in 178 of 188 patients (94.6%).

CONCLUSION:

Incorporating trichomonas rapid antigen tests and NAATs into routine female adolescent STI testing significantly increased the number of laboratory-confirmed adolescent trichomonas diagnosis and treatment and are useful Emergency Department STI screening tools.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trichomonas vaginalis / Vaginite por Trichomonas / Infecções Sexualmente Transmissíveis / Técnicas de Amplificação de Ácido Nucleico / Antígenos de Protozoários Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans Idioma: En Revista: J Pediatr Adolesc Gynecol Assunto da revista: GINECOLOGIA / PEDIATRIA Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Trichomonas vaginalis / Vaginite por Trichomonas / Infecções Sexualmente Transmissíveis / Técnicas de Amplificação de Ácido Nucleico / Antígenos de Protozoários Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies Limite: Adolescent / Adult / Female / Humans Idioma: En Revista: J Pediatr Adolesc Gynecol Assunto da revista: GINECOLOGIA / PEDIATRIA Ano de publicação: 2016 Tipo de documento: Article